Industries / Health / Healthcare / Telehealth
Prescribing
Prescribing covers writing a prescription after a consultation by video, phone or message, and the rules that say when a remote consultation is enough.
7
Milestones achieved, from 2008 to 2025.
2
To watch for: announced, not yet confirmed outside.
2
Open deliverables. Nobody has shipped them.
The road
AchievedWatch forOpen
Achieved
2008
A death changes the law
Ryan Haight, a California high school student, died in 2001 of poisoning from a controlled medicine, an opioid he had bought at 17 from an online pharmacy that never had him examined. The Ryan Haight Online Pharmacy Consumer Protection Act, approved on 15 October 2008, requires an in-person medical evaluation, "conducted with the patient in the physical presence of the practitioner", before a controlled substance is prescribed for supply over the internet. It allows exceptions for the "practice of telemedicine", one of them a special registration that the government may issue to practitioners.
Lessonthe special registration the law allowed was not proposed in detail until January 2025, and as of November 2026 it was still not final.
Credit
US Congress; Drug Enforcement Administration (DEA)
2020
Controlled drugs by video
Under the COVID-19 public health emergency, two DEA letters of 25 and 31 March 2020 let US practitioners prescribe controlled medicines (schedules II to V, the classes the law restricts because they can be misused) in a video visit without ever seeing the patient in person, and medicines for opioid addiction by phone alone. In March 2023 DEA proposed permanent rules with tighter limits; they drew 38,369 public comments, and instead of finishing them DEA extended the emergency rules four times, most recently to 31 December 2026.
Lessona temporary rule is hard to end once patients' care depends on it.
Credit
DEA (letters signed by William T. McDermott and Thomas W. Prevoznik); US Department of Health and Human Services (HHS)
2020
Abortion pills after a call
By 30 March 2020 all the governments in Great Britain had issued emergency orders letting patients take mifepristone, the first of two medicines in an early medical abortion, at home after a consultation by phone or video, with no ultrasound unless one was indicated. A study of 52,142 early medical abortions in England and Wales, 85% of those in the period, found treatment success of 98.8% after the change against 98.2% before it, serious adverse events of 0.02% against 0.04%, and waits 4.2 days shorter. Parliament made the option permanent in the Health and Care Act 2022, in force from 30 August 2022. In the US, the FDA removed its in-person dispensing requirement for mifepristone in January 2023 and says it is reviewing those rules again, with results of a safety study due in December 2026.
Credit
the governments of Great Britain; Abigail R. A. Aiken, Patricia A. Lohr, Jonathan Lord, Nabanita Ghosh and Jennifer Starling (study); US Food and Drug Administration (FDA)
2025
Addiction medicine by phone
A final rule published by DEA and HHS on 17 January 2025 lets a practitioner, after checking the state database of the patient's controlled-substance prescriptions, prescribe a first six months of buprenorphine or similar medicines for opioid addiction in a phone call alone, with the pharmacist checking the patient's identity before filling it. After two delays the rule took effect on 31 December 2025. It is the first of the permanent rules that followed the 2020 emergency letters.
Credit
DEA; HHS
2025
Questionnaires no longer enough
On 4 February 2025 the General Pharmaceutical Council (GPhC), which regulates pharmacies, told online pharmacies that for high-risk medicines, a list that now includes weight-loss drugs such as Wegovy and Mounjaro, a prescriber may not decide from an online questionnaire alone. Weight, height or body mass index must be checked independently, by video, in person, from clinical records or with the patient's GP, and a phone call is not enough for weight-loss medicines. The GPhC said its inspections had found "too many cases" of medicines supplied inappropriately online.
Credit
GPhC (chief executive Duncan Rudkin)
2025
Warning letters to online clinics
Compounded drugs are copies mixed by pharmacies, not products the FDA has approved. On 9 September 2025 the FDA announced thousands of letters about misleading drug ads and about 100 cease-and-desist letters; in the same push it sent more than 50 warning letters to wellness clinics and telehealth platforms, Hims & Hers among them, over claims that compounded semaglutide and tirzepatide, the drugs in Ozempic, Wegovy, Mounjaro and Zepbound, were comparable to the approved brands.
Credit
FDA, Center for Drug Evaluation and Research (letters signed by its director, George Tidmarsh)
2025
Leaders convicted over stimulants
Done Global sold US patients a monthly subscription for ADHD (attention deficit hyperactivity disorder) treatment online. Prosecutors showed that first visits were capped at half the length of a typical exam, an auto-refill feature sent refill requests that prescribers signed sometimes without reviewing records, and prescribers were paid up to $60,000 a month; more than 37 million pills of Adderall, a stimulant, were distributed. In November 2025 a federal jury in San Francisco convicted founder Ruthia He and clinical president David Brody, and on 7 July 2026 they were sentenced to 72 and 24 months in prison.
Lessonwhen visits are short, refills run by default and prescribers are paid by volume, an online clinic turns prescribing into a subscription sale.
Credit
US Department of Justice
Watch for
AI renews prescriptions in Utah
Under a state program that relaxes some rules for tests, Utah lets Doctronic's AI system renew prescriptions for about 190 long-term medicines; controlled substances, opioids, ADHD stimulants and injectable medicines are excluded. In each medicine category a physician must review and approve the first 250 AI decisions. A trade report says physicians agreed with the AI 91% of the time, 97% after a second physician's review, without naming who measured it; 11 members of Utah's medical licensing board asked in April 2026 for the pilot to be halted, and the state declined.
Achieved whenthe state or an independent group publishes the renewal decisions against physician review, with missed drug interactions and adverse events counted.
Claimed by
Doctronic and the Utah Office of Artificial Intelligence Policy, January 2026
A registration for remote prescribers
DEA proposed a special registration that would let registered practitioners prescribe controlled substances by video, and in limited cases by phone, without ever examining the patient in person, with extra prescription, recordkeeping and reporting duties; it would also register some direct-to-consumer telemedicine platforms. The proposal drew more than 6,475 comments, and DEA extended the emergency rules to 31 December 2026 to finish considering it. A search of the Federal Register on 18 November 2026 found no final rule.
Achieved whena final rule is published and DEA starts issuing the registrations.
Claimed by
DEA and HHS, January 2025, restated December 2025
Open
01
A renewal decision test set
A public set of at least 500 made-up renewal requests for common long-term medicines, each with a made-up chart (recent blood pressure readings, lab results, other medicines, pregnancy status, kidney function). About a fifth hide a reason not to renew automatically, such as an overdue potassium test for a blood pressure drug, a newly added interacting drug, or falling kidney function on metformin. Two pharmacists and a physician label each case renew, renew after a check, or refer, and AI renewal systems and open models are scored against them.
The briefCredit · unclaimed02
Remote prescribing rules as data
A dated table, readable by software, that codes the rules for prescribing after a remote consultation in every US state and DC and in at least 10 other countries: whether an in-person visit must come first, whether a phone call or a questionnaire counts, extra limits for controlled substances, identity checks, and whether the patient's regular doctor must be told. Every cell cites the law or guidance it comes from, two people code each jurisdiction separately, and the table is refreshed every quarter.
The briefCredit · unclaimed
Open 01 · the brief
A renewal decision test set
The first to publish is credited on this line, and the deliverable moves from Open to Achieved.
What to build
A public set of at least 500 made-up renewal requests for common long-term medicines, each with a made-up chart (recent blood pressure readings, lab results, other medicines, pregnancy status, kidney function). About a fifth hide a reason not to renew automatically, such as an overdue potassium test for a blood pressure drug, a newly added interacting drug, or falling kidney function on metformin. Two pharmacists and a physician label each case renew, renew after a check, or refer, and AI renewal systems and open models are scored against them.
Why it is still open
Utah's Doctronic pilot has published no outcome data, and Doctronic's only paper so far was written by its own scientists. The nearest public test, RxBench (November 2025), checks AI models against pharmacists on 14 kinds of prescription error, not on whether a repeat prescription should go out; a search found no public renewal test.
Built with what exists
Synthea for made-up patient histories; drug labels from the FDA's openFDA and the National Library of Medicine's DailyMed to write the hazard rules; AI models such as Claude and Gemini and open-weight models as baselines; a spreadsheet or Label Studio for the pharmacists' labels.
First step
Choose 20 common long-term medicines and write five hazard rules for each from its FDA label.
Done looks like
500 cases with at least 100 planted hazards; for each system tested, the share of hazards caught with a 95% confidence interval and the share of safe renewals needlessly referred; the pharmacists' agreement with each other reported; cases, labels and code published.
Open 02 · the brief
Remote prescribing rules as data
The first to publish is credited on this line, and the deliverable moves from Open to Achieved.
What to build
A dated table, readable by software, that codes the rules for prescribing after a remote consultation in every US state and DC and in at least 10 other countries: whether an in-person visit must come first, whether a phone call or a questionnaire counts, extra limits for controlled substances, identity checks, and whether the patient's regular doctor must be told. Every cell cites the law or guidance it comes from, two people code each jurisdiction separately, and the table is refreshed every quarter.
Why it is still open
The Center for Connected Health Policy keeps an "Online Prescribing" page with a text summary for each state, updated through 2026, but no downloadable data was found. LawAtlas's telehealth dataset codes only whether non-physician providers may give primary care by telehealth, in law from the 2010s. The rules are moving: the US emergency rules expire on 31 December 2026 and Britain's pharmacy regulator rewrote its online guidance in 2025.
Built with what exists
The coding method LawAtlas publishes with its datasets (a codebook and a protocol); official law and regulator websites; an AI model such as Claude to draft codes from the text of each law, with every code checked by a person; GitHub for versions and changes.
First step
Write the 12 questions from the Ryan Haight Act, DEA's 2025 proposal and the GPhC's 2025 guidance, and code five states.
Done looks like
51 US jurisdictions and 10 countries coded on 12 questions, the two coders agreeing on at least 90% of cells before they reconcile, every cell cited, a CSV file and codebook published, and a new version released within a month of the 31 December 2026 US deadline.